Abstract
(−)Nicotine acetylcholine receptors are located on both nerve cell bodies and synaptic terminals, are permeable to calcium, and function perhaps predominantly by facilitating the release of neurotransmitters and neuropeptides. The behavioral rewards from (−)nicotine and perhaps addiction appear to be related to dopamine release. 31P NMR analysis reveals subcutaneously administered (−)nicotine produces acute alterations in brain membrane phospholipid and high-energy phosphate metabolism of Fischer 344 rats. These metabolic responses to (−)nicotine could contribute to nicotine's behavioral effects.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
REFERENCES
Henningfield, J. E., Stapleton, J. M., Benowitz, N. L., Grayson, R. F., and London, E. D. 1993. Higher levels of nicotine in arterial than in venous blood after cigarette smoking. Drug Alcohol Depend. 33:23–29.
Taioli, E. and Wynder, E. L. 1991. Affect of the age at which smoking begins on frequency of smoking in adulthood. N. Engl. J. Med. 325:968–969.
Lena, C. and Changeux, J.-P. 1993. Allosteric modulations of the nicotinic acetylcholine receptor. Trends Neurosci. 16:181–186.
Collins, A. C., Luo, Y., Selvaag, S., and Marks, M. J. 1994. Sensitivity to nicotine and brain nicotinic receptors are altered by chronic nicotine and mecamylamine infusion. J. Pharmacol. Exp. Ther. 271:125–133.
Benwell, M. E. M., Balfour, D. J. K., and Anderson, J. M. 1988. Evidence that tobacco smoking increases the density of (-)-[3H]nicotine binding sites in human brain. J. Neurochem. 50:1243–1247.
Peng, X., Gerzanich, V., Anand, R., Whiting, P. J., and Lindstrom, J. 1994. Nicotine-induced increase in neuronal nicotinic receptors results from a decrease in the rate of receptor turnover. Mol. Pharmacol. 46:523–530.
Madhok, T. C., Beyer, H. S., and Sharp, B. M. 1994. Protein kinase A regulates nicotinic cholinergic receptors and subunit messenger ribonucleic acids in PC 12 cells. Endocrinology 134:91–96.
Benowitz, N. L. 1996. Pharmacology of nicotine: Addiction and therapeutics. Annu. Rev. Pharmacol. Toxicol. 36:597–613.
Corrigall, W. A., Coen, K. M., and Adamson, K. L. 1994. Selfadministered nicotine activates the mesolimbic dopamine system through the ventral tegmental area. Brain Res. 653:278–284.
Smith, D. G., Mills, W. J., Steen, R. G., and Williams, D. 1999. Levels of high energy phosphate in the dorsal skin of the foot in normal and diabetic adults: the role of 31P magnetic resonance spectroscopy and direct quantification with high pressure liquid chromatography. Foot Ankle Int. 20:258–262.
Toth, E., Vizi, E. S., and Lajtha, A. 1993. Effect of nicotine on levels of extracellular amino acids in regions of the rat brain in vivo. Neuropharmacol. 32:827–832.
Pettegrew, J. W., Panchalingam, K., Withers, G., McKeag, D., and Strychor, S. 1990. Changes in brain energy and phospholipid metabolism during development and aging in the Fischer 344 rat. J. Neuropathol. Exp. Neurol. 49:237–249.
Meneses, P. and Glonek, T. 1988. High resolution 31P NMR of extracted phospholipids. J. Lipid Res. 29:679–690.
Klunk, W. E., Xu, C. J., Panchalingam, K., McClure, R. J., and Pettegrew, J. W. 1994. Analysis of magnetic resonance spectra by mole percent: Comparison to absolute units. Neurobiol. Aging 15:133–140.
Meneses, P., Para, P. F., and Glonek, T. 1989. 31P NMR of tissue phospholipids: A comparison of three tissue pre-treatment procedures. J. Lipid Res. 30:458–461.
Vance, J. E. 1988. Compartmentalization of phospholipids for lipoprotein assembly on the basis of molecular species and biosynthetic origin. Biochim. Biophys. Acta 963:70–81.
Vance, D. E. 1991. Phospholipid metabolism and cell signalling in eucaryotes. Pages 205–240, in Vance, D. E., and Vance, J. (eds.), Biochemistry of lipids, lipoproteins and membranes, Volume 20, Elsevier, New York.
Geddes, J. W., Panchalingam, K., Keller, J. N., and Pettegrew, J. W. 1997. Elevated phosphocholine and phosphatidyl choline following rate entorhinal cortex lesions. Neurobiol. Aging 18: 305–308.
Robinson, N. C. 1993. Functional binding of cardiolipin to cytochrome c oxidase. J. Bioenerg. Biomembr. 25:153–163.
McAuley, K. E., Fyfe, P. K., Ridge, J. P., Isaacs, N. W., Cogdell, R. J., and Jones, M. R. 1999. Structural details of an interaction between cardiolipin and an integral membrane protein. Proc. Natl. Acad. Sci. USA 96:14706–14711.
Sastry, B. V., Chance, M. B., Hemontolor, M. E., and Goddijn-Wessel, T. A. 1998. Formation and retention of cotinine during placental transfer of nicotine in human placental cotyledon. Pharmacology 57:104–116.
Sastry, B. V. and Hemontolor, M. E. 1998. Influence of nicotine and cotinine on retinal phospholipase A2 and its significance to macular function. J. Ocular Pharmacol. Therap. 14:447–458.
Agranoff, B. W. and Hajra, A. K. 1994. Lipids. Pages 97–116, in Siegel, G. J., Agranoff, B. W., Albers, R. W., and Molinoff, P. B. (eds.), Basic Neurochemistry, Molecular, Cellular, and Medical Aspects, Raven Press, New York.
Wallimann, T. and Hemmer, W. 1994. Creatine kinase in nonmuscle tissues and cells. Mol. Cell. Biochem. 133-134:193–220.
Xu, C. J., Klunk, W. E., Kanfer, J. N., Xiong, Q., Miller, G., and Pettegrew, J. W. 1996. Phosphocreatine-dependent glutamate uptake by synaptic vesicles. A comparison with ATP dependent glutamate uptake. J. Biol. Chem. 271:13435–13440.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Pettegrew, J.W., Panchalingam, K., McClure, R.J. et al. Brain Metabolic Effects of Acute Nicotine. Neurochem Res 26, 181–185 (2001). https://doi.org/10.1023/A:1011007131195
Issue Date:
DOI: https://doi.org/10.1023/A:1011007131195